Achieve therapeutic targets and improve sample efficiency. InsightRX Nova standardizes precision dosing across your institution, improving efficacy, minimizing variability, and reducing adverse events—all while lowering blood sampling by up to 50%. Improve model accuracy and stay up to date. InsightRX Nova gives you access to the most up to date, clinically validated models developed by our partners and curated from the literature. In addition, dosing guidance improves over time as we update models using our proprietary human-assisted AI framework and data from the InsightRX network. Capture results and outcomes. InsightRX Nova includes reports on your institution’s target performance compared to national benchmarks or your institutional data. For more powerful analytics, InsightRX Apollo provides dashboards enabling you to understand how targets are being met across drugs, providers, and subpopulations.

InsightRX provides software that helps clinicians optimize dosing regimens, reach clinical targets faster, reduce adverse events, and improve patient outcomes.

Jvion helps healthcare systems and providers prevent harm and lower costs through its AI-enabled prescriptive analytics solution. An industry first, the Jvion Machine™ goes beyond simple predictive analytics and machine learning to identify patients on a trajectory to becoming high risk and for whom intervention will likely be successful. Jvion determines the interventions that will more effectively reduce risk and enable clinical action. And it accelerates time to value by leveraging established patient-level intelligence to drive engagement across hospitals, populations, and patients.

Preventable harm is preventable. Jvion helps healthcare systems prevent patient harm and associated costs by enabling clinical staff to focus attention, resources, and individualized interventions on patients whose outcomes can be improved. Unlike traditional AI and predictive analytic solutions that merely identify high-risk patients and cause alarm fatigue, Jvion pinpoints the impactable patients who are on a risk trajectory that can be changed and provides the patient-specific recommendations that will drive to a better outcome. The Jvion Machine™ is a combination of Eigen-based mathematics, dataset of more than 16 million patients, and software that can be quickly applied to any of 50 preventable harm vectors (such as sepsis, readmissions, falls, avoidable ER visits, and pressure injuries) without the need to create new models or to have perfect data. As the leader in prescriptive analytics for preventable harm, Jvion has proven effective in clinical settings for nearly a decade, with hospitals reporting average reductions of 30% in preventable harm incidents and avoidable cost savings of $6.3 million a year.